| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1159/000092104 |
| P698 | PubMed publication ID | 16549939 |
| P2093 | author name string | Johnson CD | |
| Martínez J | |||
| de Madaria E | |||
| Pérez-Mateo M | |||
| Robles-Díaz G | |||
| Sánchez-Payá J | |||
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| meta-analysis | Q815382 | ||
| acute pancreatitis | Q854573 | ||
| risk factor | Q1475848 | ||
| P304 | page(s) | 206-209 | |
| P577 | publication date | 2006-03-17 | |
| P1433 | published in | Pancreatology | Q15750271 |
| P1476 | title | Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis | |
| P478 | volume | 6 |
| Q89766279 | A body mass index ≥25 kg/m2 is associated with a poor prognosis in patients with acute pancreatitis: a study of Japanese patients |
| Q53210315 | A large volume of visceral adipose tissue leads to severe acute pancreatitis. |
| Q43586910 | A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis |
| Q44813278 | Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study |
| Q43088026 | Acute pancreatitis at the beginning of the 21st century: the state of the art. |
| Q83468592 | Acute pancreatitis in obesity: adipokines and dietary fish oil |
| Q38223927 | Acute pancreatitis in patients after bariatric surgery: incidence, outcomes, and risk factors |
| Q42084167 | Acute pancreatitis--from cellular signalling to complicated clinical course. |
| Q37878986 | Acute pancreatitis: should we use antibiotics? |
| Q43162308 | Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice |
| Q48180687 | Analysis of Factors Associated with the Severity of Acute Pancreatitis according to Etiology. |
| Q52946049 | Analysis of factors influencing survival in patients with severe acute pancreatitis. |
| Q36009171 | Association between severity and the determinant-based classification, Atlanta 2012 and Atlanta 1992, in acute pancreatitis: a clinical retrospective study |
| Q64064292 | Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis |
| Q61796236 | Body-mass index correlates with severity and mortality in acute pancreatitis: A meta-analysis |
| Q64120161 | Can C-reactive Protein Increase the Efficiency of the Bedside Index of Severity in Acute Pancreatitis Scoring System? |
| Q46117920 | Cannabinoid receptor-1 blockade attenuates acute pancreatitis in obesity by an adiponectin mediated mechanism |
| Q93200379 | Dietary Fat Patterns and Outcomes in Acute Pancreatitis in Spain |
| Q34369134 | Differences in the inflammatory response induced by acute pancreatitis in different white adipose tissue sites in the rat. |
| Q64379695 | Does adiponectin upregulation attenuate the severity of acute pancreatitis in obesity? |
| Q44532386 | EUS and related technologies for the diagnosis and treatment of pancreatic disease: research gaps and opportunities-Summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop. |
| Q45232495 | Editorial: abdominal fat: a key player in metabolic acute pancreatitis |
| Q35898337 | Effect of diabetes on severity and hospital mortality in patients with acute pancreatitis: a national population-based study |
| Q33385913 | Effect of diet-induced obesity on acute pancreatitis induced by administration of interleukin-12 plus interleukin-18 in mice |
| Q30370467 | Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. |
| Q39630649 | Effects of abdominal fat distribution parameters on severity of acute pancreatitis |
| Q44815018 | Endoscopic Ultrasound and Related Technologies for the Diagnosis and Treatment of Pancreatic Disease - Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop |
| Q38340339 | Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents |
| Q42635282 | Experimental evidence of obesity as a risk factor for severe acute pancreatitis |
| Q37767363 | Fatal acute pancreatitis occurring outside of the hospital: clinical and social characteristics |
| Q41812960 | Gastric lipase secretion in children with gastritis |
| Q34996696 | Gastrointestinal issues in the assessment and management of the obese patient |
| Q35091299 | Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia. |
| Q84785337 | High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice |
| Q51827882 | Hyperglycemia and Diabetes Mellitus in Children with Pancreatitis |
| Q40849807 | Impact of obesity on outcomes of paediatric acute pancreatitis based on a national administrative database |
| Q92726245 | Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis |
| Q43719119 | Implementation of the Asia-Pacific guidelines of obesity classification on the APACHE-O scoring system and its role in the prediction of outcomes of acute pancreatitis: a study from India |
| Q42030517 | Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes |
| Q64926900 | Influence of age, body mass index and comorbidity on major outcomes in acute pancreatitis, a prospective nation-wide multicentre study. |
| Q35195456 | Influence of obesity on the severity and clinical outcome of acute pancreatitis |
| Q34270508 | Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice |
| Q36725696 | Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice |
| Q38041420 | Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents |
| Q89207728 | Leptin alleviates intestinal mucosal barrier injury and inflammation in obese mice with acute pancreatitis |
| Q92624187 | Low Serum Ionized Calcium, Elevated High-Sensitivity C-Reactive Protein, Neutrophil-Lymphocyte Ratio, and Body Mass Index (BMI) Are Risk Factors for Severe Acute Pancreatitis in Patients with Hypertriglyceridemia Pancreatitis |
| Q91994744 | Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissue |
| Q40413860 | Morbid Obesity Is Associated With Adverse Clinical Outcomes in Acute Pancreatitis: A Propensity-Matched Study |
| Q92704863 | Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice |
| Q36327145 | New advances in acute pancreatitis |
| Q36845768 | No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks |
| Q36408436 | Nonalcoholic fatty pancreas disease |
| Q37539722 | Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea? |
| Q37466922 | Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology |
| Q34427069 | Obese rats exhibit high levels of fat necrosis and isoprostanes in taurocholate-induced acute pancreatitis |
| Q93003221 | Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection |
| Q46788665 | Obesity alters cytokine gene expression and promotes liver injury in rats with acute pancreatitis |
| Q30416191 | Obesity and the risk and outcome of infection |
| Q87282501 | Obesity as a risk factor for severe acute pancreatitis patients |
| Q57943356 | Obesity, metabolic disease and the pancreas—Quantitative imaging of pancreatic fat |
| Q37194628 | Obesity, pancreatitis, and pancreatic cancer |
| Q50178942 | Paediatric necrotizing pancreatitis |
| Q37594792 | Pharmacotherapy of hyperglycemia |
| Q36785154 | Predicting severity of acute pancreatitis |
| Q35178638 | Redox signaling in acute pancreatitis |
| Q55041188 | Relationship between low-density lipoprotein cholesterol and severe acute pancreatitis ("the lipid paradox"). |
| Q34467273 | Resistin is not an appropriate biochemical marker to predict severity of acute pancreatitis: a case-controlled study |
| Q41957488 | Resistin: New serum marker for predicting severity of acute pancreatitis |
| Q37684581 | Risk Factors for Worsening of Acute Pancreatitis in Patients Admitted with Mild Acute Pancreatitis |
| Q88538406 | Role of obesity in the release of extracellular nucleosomes in acute pancreatitis: a clinical and experimental study |
| Q35780935 | Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials |
| Q36975579 | Serum adipokine concentrations in dogs with acute pancreatitis. |
| Q37060412 | Severe acute pancreatitis: pathogenetic aspects and prognostic factors |
| Q50332667 | The Burden of Systemic Adiposity on Pancreatic Disease: Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer. |
| Q43714918 | The adipocytokine resistin stimulates the production of proinflammatory cytokines TNF-α and IL-6 in pancreatic acinar cells via NF-κB activation |
| Q37838235 | The clinical significance of pancreatic steatosis |
| Q37219592 | The epidemiology of obesity and gastrointestinal and other diseases: an overview |
| Q37059698 | The impact of obesity on the course and outcome of acute pancreatitis |
| Q33888248 | The medical risks of obesity |
| Q34551353 | The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists |
| Q52535715 | The role of multidisciplinary meetings for benign pancreatobiliary diseases: a tertiary centre experience. |
| Q48233504 | Type 2 diabetes: Does pancreatic fat really matter? |
| Q36450509 | Value of adipokines in predicting the severity of acute pancreatitis: comprehensive review |
Search more.